Ginkgo Bioworks Announces Date of Third Quarter 2022 Results Presentation
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session to discuss its third-quarter results for 2022 on November 14, 2022, at 4:30 p.m. ET.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session to discuss its third-quarter results for 2022 on November 14, 2022, at 4:30 p.m. ET. The session will review the company's business performance for the quarter ending September 30, 2022. Investors can access details and a replay on Ginkgo's investor relations website. The company focuses on biotechnology applications across various markets, including agriculture and pharmaceuticals while contributing to COVID-19 response efforts.
Positive
- Scheduled presentation indicates transparency and engagement with investors.
- Focus on diverse biotechnological applications demonstrates strong market positioning.
Negative
- None.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was -4.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Presentation and Q&A session scheduled for post-market on Monday, November 14, 2022
BOSTON, Nov. 7, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2022, on Monday, November 14, 2022, beginning at 4:30 p.m. ET.
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2022-results-presentation-301670154.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.